Pancreatic cancer environment: From patient-derived models to single-cell omics
Pancreatic cancer (PC) is a highly malignant cancer characterized by poor prognosis, high
heterogeneity, and intricate heterocellular systems. Selecting an appropriate experimental …
heterogeneity, and intricate heterocellular systems. Selecting an appropriate experimental …
[HTML][HTML] A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy
CWF van Eijck, S Sabroso-Lasa, GJ Strijk… - Neoplasia, 2024 - Elsevier
Background Pancreatic ductal adenocarcinoma (PDAC) is often treated with FOLFIRINOX, a
chemotherapy associated with high toxicity rates and variable efficacy. Therefore, it is crucial …
chemotherapy associated with high toxicity rates and variable efficacy. Therefore, it is crucial …
[HTML][HTML] Immunogenicity and Safety of COVID-19 Vaccines in Patients with Pancreatic Cancer
Background Patients with pancreatic ductal adenocarcinoma (PDAC) are at increased risk
for severe COVID-19. Although COVID-19 vaccines are crucial for this population, studies on …
for severe COVID-19. Although COVID-19 vaccines are crucial for this population, studies on …